Figure 14 shows that FANCD2 expression negatively correlated with the IC50 value of sorafenib in Hepatitis B-related HCC (P, 4.16e-05; Spearman, −0.33; CL 95%, [−0.47, −0.18]). The gene discussed is FANCD2; the disease is hepatocellular carcinoma.